{
  "m_q": {
    "target_metric": {
      "value": "List of protein sites (phosphorylation or acetylation sites) that are hyperactivated in CNV-high endometrioid samples and are targeted by FDA-approved drugs",
      "confidence": 0.3333333333333333,
      "votes": [
        "List of protein sites (phosphorylation or acetylation sites) that are hyperactivated in CNV-high endometrioid samples and are targeted by FDA-approved drugs",
        "Protein sites that are hyperactivated in CNV-high endometrioid samples and targeted by FDA-approved drugs",
        "List of protein sites hyperactivated in CNV-high endometroid samples and targeted by FDA-approved drugs"
      ]
    },
    "filters": {
      "value": [
        "Histologic_type = 'Endometrioid'",
        "CNV_class = 'CNV_HIGH' (or similar high CNV classification)",
        "Hyperactivation defined by significant positive FoldChange in phospho/acetyl sites with appropriate statistical thresholds (e.g., FDR < 0.05, FoldChange > threshold)",
        "Histologic_type == 'Endometrioid'",
        "CNV_class == 'CNV_HIGH'",
        "Hyperactivated proteins from hyperactivated.csv",
        "FDA-approved drug targets from 1-s2.0-S0092867420301070-mmc6__G-FDA approved drugs",
        "Samples with CNV_class = 'CNV_HIGH' and Histologic_type = 'Endometrioid'",
        "Protein sites that are hyperactivated",
        "Proteins targeted by FDA-approved drugs"
      ],
      "confidence": 0.33333333333333337,
      "votes": [
        [
          "Histologic_type = 'Endometrioid'",
          "CNV_class = 'CNV_HIGH' (or similar high CNV classification)",
          "Hyperactivation defined by significant positive FoldChange in phospho/acetyl sites with appropriate statistical thresholds (e.g., FDR < 0.05, FoldChange > threshold)"
        ],
        [
          "Histologic_type == 'Endometrioid'",
          "CNV_class == 'CNV_HIGH'",
          "Hyperactivated proteins from hyperactivated.csv",
          "FDA-approved drug targets from 1-s2.0-S0092867420301070-mmc6__G-FDA approved drugs"
        ],
        [
          "Samples with CNV_class = 'CNV_HIGH' and Histologic_type = 'Endometrioid'",
          "Protein sites that are hyperactivated",
          "Proteins targeted by FDA-approved drugs"
        ]
      ]
    },
    "grouping_variables": {
      "value": [
        "ID (protein site identifier)",
        "Gene",
        "sample_id",
        "CNV_class",
        "Histologic_type"
      ],
      "confidence": 0.3333333333333333,
      "votes": [
        [
          "ID (protein site identifier)",
          "Gene"
        ],
        [
          "sample_id",
          "CNV_class",
          "Histologic_type"
        ],
        []
      ]
    },
    "output_cardinality": {
      "value": "list",
      "confidence": 1.0,
      "votes": [
        "list",
        "list",
        "list"
      ]
    },
    "sub_questions": {
      "value": [
        "Which samples are CNV-high endometrioid?",
        "Which protein sites are hyperactivated in these samples?",
        "Which of those sites correspond to genes targeted by FDA-approved drugs?",
        "What drugs target those genes?",
        "Which samples are CNV-high endometrioid samples?",
        "Which proteins are hyperactivated in these samples?",
        "Which of these hyperactivated proteins are targeted by FDA-approved drugs?",
        "What are the specific phosphorylation or acetylation sites for these proteins?",
        "Identify CNV-high endometroid samples from the clinical data.",
        "Determine which protein sites are hyperactivated in these samples.",
        "Identify FDA-approved drugs and their target proteins.",
        "Find the intersection of hyperactivated protein sites and FDA-approved drug targets."
      ],
      "confidence": 0.3333333333333333,
      "votes": [
        [
          "Which samples are CNV-high endometrioid?",
          "Which protein sites are hyperactivated in these samples?",
          "Which of those sites correspond to genes targeted by FDA-approved drugs?",
          "What drugs target those genes?"
        ],
        [
          "Which samples are CNV-high endometrioid samples?",
          "Which proteins are hyperactivated in these samples?",
          "Which of these hyperactivated proteins are targeted by FDA-approved drugs?",
          "What are the specific phosphorylation or acetylation sites for these proteins?"
        ],
        [
          "Identify CNV-high endometroid samples from the clinical data.",
          "Determine which protein sites are hyperactivated in these samples.",
          "Identify FDA-approved drugs and their target proteins.",
          "Find the intersection of hyperactivated protein sites and FDA-approved drug targets."
        ]
      ]
    }
  },
  "m_s": {
    "sources": {
      "value": [
        "1-s2.0-S0092867420301070-mmc1.xlsx",
        "1-s2.0-S0092867420301070-mmc6__B-SE phospho site between Serou",
        "1-s2.0-S0092867420301070-mmc6__C-SE scetyl site between Serous",
        "1-s2.0-S0092867420301070-mmc6__G-FDA approved drugs",
        "hyperactivated.csv",
        "1-s2.0-S0092867420301070-mmc6__E-SE phospho site between MSI-H",
        "1-s2.0-S0092867420301070-mmc6.xlsx"
      ],
      "confidence": 0.7619047619047618,
      "votes": [
        [
          "1-s2.0-S0092867420301070-mmc1.xlsx",
          "1-s2.0-S0092867420301070-mmc6__B-SE phospho site between Serou",
          "1-s2.0-S0092867420301070-mmc6__C-SE scetyl site between Serous",
          "1-s2.0-S0092867420301070-mmc6__G-FDA approved drugs",
          "hyperactivated.csv"
        ],
        [
          "1-s2.0-S0092867420301070-mmc1.xlsx",
          "hyperactivated.csv",
          "1-s2.0-S0092867420301070-mmc6__G-FDA approved drugs",
          "1-s2.0-S0092867420301070-mmc6__B-SE phospho site between Serou",
          "1-s2.0-S0092867420301070-mmc6__E-SE phospho site between MSI-H"
        ],
        [
          "1-s2.0-S0092867420301070-mmc1.xlsx",
          "1-s2.0-S0092867420301070-mmc6.xlsx",
          "1-s2.0-S0092867420301070-mmc6__B-SE phospho site between Serou",
          "1-s2.0-S0092867420301070-mmc6__C-SE scetyl site between Serous",
          "1-s2.0-S0092867420301070-mmc6__G-FDA approved drugs",
          "hyperactivated.csv"
        ]
      ]
    },
    "schema_conflicts": {
      "value": [
        "Different naming conventions for CNV classification (CNV_class vs CNV_idx)",
        "Protein site IDs in phospho/acetyl sheets contain gene and site info (e.g., 'AAAS-S495') while hyperactivated.csv has only protein names",
        "Multiple drug entries per gene in FDA sheet",
        "Gene name column varies: 'protein' in hyperactivated.csv, 'gene_name' in FDA drugs, 'Gene' in phospho site sheets",
        "Sample ID column varies: 'idx' in mmc1, 'sample_id' in hyperactivated.csv",
        "The 'ID' column in '1-s2.0-S0092867420301070-mmc6__B-SE phospho site between Serou' and '1-s2.0-S0092867420301070-mmc6__C-SE scetyl site between Serous' has different meanings. One represents phospho/acetyl site ID, the other represents protein ID.",
        "The 'gene_name' column in '1-s2.0-S0092867420301070-mmc6__G-FDA approved drugs' and '1-s2.0-S0092867420301070-mmc6__B-SE phospho site between Serou'/'1-s2.0-S0092867420301070-mmc6__C-SE scetyl site between Serous' refers to the same concept but might have different naming conventions."
      ],
      "confidence": 0.3333333333333333,
      "votes": [
        [
          "Different naming conventions for CNV classification (CNV_class vs CNV_idx)",
          "Protein site IDs in phospho/acetyl sheets contain gene and site info (e.g., 'AAAS-S495') while hyperactivated.csv has only protein names",
          "Multiple drug entries per gene in FDA sheet"
        ],
        [
          "Gene name column varies: 'protein' in hyperactivated.csv, 'gene_name' in FDA drugs, 'Gene' in phospho site sheets",
          "Sample ID column varies: 'idx' in mmc1, 'sample_id' in hyperactivated.csv"
        ],
        [
          "The 'ID' column in '1-s2.0-S0092867420301070-mmc6__B-SE phospho site between Serou' and '1-s2.0-S0092867420301070-mmc6__C-SE scetyl site between Serous' has different meanings. One represents phospho/acetyl site ID, the other represents protein ID.",
          "The 'gene_name' column in '1-s2.0-S0092867420301070-mmc6__G-FDA approved drugs' and '1-s2.0-S0092867420301070-mmc6__B-SE phospho site between Serou'/'1-s2.0-S0092867420301070-mmc6__C-SE scetyl site between Serous' refers to the same concept but might have different naming conventions."
        ]
      ]
    }
  },
  "m_u": {
    "unit_annotations": {
      "value": {
        "foldchange.protein": "log2 fold change",
        "foldchange.phos": "log2 fold change",
        "foldchange.acetyl": "log2 fold change",
        "foldchange.rna": "log2 fold change",
        "pval.*": "p-value",
        "fdr.*": "false discovery rate",
        "cnv_del": "copy number deletion score",
        "cnv_amp": "copy number amplification score",
        "pval.phos": "p-value",
        "fdr.phos": "false discovery rate",
        "pval.protein": "p-value",
        "logp.protein": "-log10(p-value)",
        "fdr.protein": "False Discovery Rate"
      },
      "confidence": 0.4358974358974358,
      "votes": [
        {
          "FoldChange.protein": "log2 fold change",
          "FoldChange.phos": "log2 fold change",
          "FoldChange.acetyl": "log2 fold change",
          "FoldChange.rna": "log2 fold change",
          "pval.*": "p-value",
          "FDR.*": "false discovery rate",
          "CNV_DEL": "copy number deletion score",
          "CNV_AMP": "copy number amplification score"
        },
        {
          "FoldChange.phos": "log2 fold change",
          "pval.phos": "p-value",
          "FDR.phos": "false discovery rate",
          "CNV_DEL": "copy number variation deletion score",
          "CNV_AMP": "copy number variation amplification score"
        },
        {
          "FoldChange.protein": "log2 fold change",
          "pval.protein": "p-value",
          "logp.protein": "-log10(p-value)",
          "FDR.protein": "False Discovery Rate"
        }
      ]
    },
    "scale_issues": {
      "value": [
        "FoldChange values appear to be on different scales across datasets",
        "CNV_class is categorical while CNV_idx is numeric",
        "Some p-values are extremely small (e.g., 1.9698205776291e-05)",
        "CNV_class is categorical (CNV_HIGH, CNV_LOW) but derived from numeric CNV_DEL and CNV_AMP scores",
        "Fold change values may be in log2 scale requiring interpretation"
      ],
      "confidence": 0.3333333333333333,
      "votes": [
        [
          "FoldChange values appear to be on different scales across datasets",
          "CNV_class is categorical while CNV_idx is numeric",
          "Some p-values are extremely small (e.g., 1.9698205776291e-05)"
        ],
        [
          "CNV_class is categorical (CNV_HIGH, CNV_LOW) but derived from numeric CNV_DEL and CNV_AMP scores",
          "Fold change values may be in log2 scale requiring interpretation"
        ],
        []
      ]
    },
    "cross_source_conflicts": {
      "value": [
        "hyperactivated.csv lists protein names but phospho/acetyl sheets use site-specific IDs",
        "CNV classification criteria not explicitly defined across sources",
        "Protein/gene naming conventions may differ between hyperactivated list and drug target databases",
        "Site nomenclature (e.g., S495, T389) needs to be parsed from ID column in phospho site sheets"
      ],
      "confidence": 0.3333333333333333,
      "votes": [
        [
          "hyperactivated.csv lists protein names but phospho/acetyl sheets use site-specific IDs",
          "CNV classification criteria not explicitly defined across sources"
        ],
        [
          "Protein/gene naming conventions may differ between hyperactivated list and drug target databases",
          "Site nomenclature (e.g., S495, T389) needs to be parsed from ID column in phospho site sheets"
        ],
        []
      ]
    }
  },
  "m_f": {
    "has_header": {
      "value": true,
      "confidence": 1.0,
      "votes": [
        true,
        true,
        true
      ]
    },
    "delimiter": {
      "value": ",",
      "confidence": 1.0,
      "votes": [
        ",",
        ",",
        ","
      ]
    },
    "encoding": {
      "value": "utf-8",
      "confidence": 1.0,
      "votes": [
        "utf-8",
        "utf-8",
        "utf-8"
      ]
    },
    "sentinel_values": {
      "value": [
        "NA",
        "N/A",
        "",
        "Cannot be determined"
      ],
      "confidence": 0.9166666666666666,
      "votes": [
        [
          "NA",
          "N/A",
          "",
          "Cannot be determined"
        ],
        [
          "NA",
          "N/A",
          "",
          "Cannot be determined"
        ],
        [
          "NA",
          "N/A",
          ""
        ]
      ]
    },
    "expected_columns": {
      "value": 10.0,
      "confidence": 0.33,
      "votes": [
        10.0,
        179.0,
        2.0
      ]
    },
    "file_format": {
      "value": "csv",
      "confidence": 0.6666666666666666,
      "votes": [
        "csv",
        "xlsx/csv",
        "csv"
      ]
    }
  },
  "m_c": {
    "constraints": {
      "value": [
        "Only endometrioid histology samples",
        "Only CNV-high samples (need to define threshold from CNV_class or CNV_idx)",
        "Statistical significance: FDR < 0.05 for phospho/acetyl sites",
        "Hyperactivation: positive FoldChange in phospho/acetyl sites",
        "Must have corresponding FDA-approved drug targeting the gene",
        "Histologic_type must equal 'Endometrioid'",
        "CNV_class must equal 'CNV_HIGH'",
        "Protein must appear in hyperactivated.csv for corresponding sample",
        "Protein must have matching gene_name in FDA approved drugs list",
        "Case_excluded should be 'No' to include valid samples",
        "CNV_class must be 'CNV_HIGH' to be considered CNV-high.",
        "Histologic_type must be 'Endometrioid' to be considered endometroid.",
        "FoldChange.phos/FoldChange.acetyl should be positive and statistically significant (e.g., pval < 0.05) to be considered hyperactivated."
      ],
      "confidence": 0.3333333333333333,
      "votes": [
        [
          "Only endometrioid histology samples",
          "Only CNV-high samples (need to define threshold from CNV_class or CNV_idx)",
          "Statistical significance: FDR < 0.05 for phospho/acetyl sites",
          "Hyperactivation: positive FoldChange in phospho/acetyl sites",
          "Must have corresponding FDA-approved drug targeting the gene"
        ],
        [
          "Histologic_type must equal 'Endometrioid'",
          "CNV_class must equal 'CNV_HIGH'",
          "Protein must appear in hyperactivated.csv for corresponding sample",
          "Protein must have matching gene_name in FDA approved drugs list",
          "Case_excluded should be 'No' to include valid samples"
        ],
        [
          "CNV_class must be 'CNV_HIGH' to be considered CNV-high.",
          "Histologic_type must be 'Endometrioid' to be considered endometroid.",
          "FoldChange.phos/FoldChange.acetyl should be positive and statistically significant (e.g., pval < 0.05) to be considered hyperactivated."
        ]
      ]
    },
    "derived_filters": {
      "value": [
        "Filter mmc1 for Histologic_type = 'Endometrioid'",
        "Filter mmc1 for CNV_class indicating high CNV (or CNV_idx > threshold)",
        "Filter phospho/acetyl sheets for FDR.phos/FDR.acetyl < 0.05 and FoldChange.phos/FoldChange.acetyl > 0",
        "Filter FDA sheet for unique gene-drug pairs",
        "Filter samples where Histologic_type contains 'Endometrioid'",
        "Identify CNV-high samples using CNV_class column",
        "Cross-reference hyperactivated proteins with FDA drug targets",
        "Extract protein sites from ID column in phospho site data",
        "CNV-high endometroid samples: CNV_class = 'CNV_HIGH' and Histologic_type = 'Endometrioid'",
        "Hyperactivated protein sites: FoldChange.phos/FoldChange.acetyl > 0 and pval.phos/pval.acetyl < 0.05"
      ],
      "confidence": 0.33333333333333337,
      "votes": [
        [
          "Filter mmc1 for Histologic_type = 'Endometrioid'",
          "Filter mmc1 for CNV_class indicating high CNV (or CNV_idx > threshold)",
          "Filter phospho/acetyl sheets for FDR.phos/FDR.acetyl < 0.05 and FoldChange.phos/FoldChange.acetyl > 0",
          "Filter FDA sheet for unique gene-drug pairs"
        ],
        [
          "Filter samples where Histologic_type contains 'Endometrioid'",
          "Identify CNV-high samples using CNV_class column",
          "Cross-reference hyperactivated proteins with FDA drug targets",
          "Extract protein sites from ID column in phospho site data"
        ],
        [
          "CNV-high endometroid samples: CNV_class = 'CNV_HIGH' and Histologic_type = 'Endometrioid'",
          "Hyperactivated protein sites: FoldChange.phos/FoldChange.acetyl > 0 and pval.phos/pval.acetyl < 0.05"
        ]
      ]
    },
    "statistical_tests": {
      "value": [
        "Differential expression/phosphorylation/acetylation tests already performed in provided sheets",
        "Need to apply multiple testing correction (FDR already provided)",
        "No statistical tests required - this is a lookup/intersection analysis"
      ],
      "confidence": 0.3333333333333333,
      "votes": [
        [
          "Differential expression/phosphorylation/acetylation tests already performed in provided sheets",
          "Need to apply multiple testing correction (FDR already provided)"
        ],
        [
          "No statistical tests required - this is a lookup/intersection analysis"
        ],
        []
      ]
    },
    "output_format_requirements": {
      "value": [
        "List of protein sites with: ID, Gene, Modification type, FoldChange, FDR, Associated drug names",
        "Should include both phospho and acetyl sites meeting criteria",
        "List of protein sites (gene + site notation)",
        "Associated FDA-approved drugs for each site/protein",
        "Sample IDs where hyperactivation occurs",
        "Include drug names and interaction types",
        "The output should be a list of unique protein sites.",
        "The list should be sorted alphabetically."
      ],
      "confidence": 0.3333333333333333,
      "votes": [
        [
          "List of protein sites with: ID, Gene, Modification type, FoldChange, FDR, Associated drug names",
          "Should include both phospho and acetyl sites meeting criteria"
        ],
        [
          "List of protein sites (gene + site notation)",
          "Associated FDA-approved drugs for each site/protein",
          "Sample IDs where hyperactivation occurs",
          "Include drug names and interaction types"
        ],
        [
          "The output should be a list of unique protein sites.",
          "The list should be sorted alphabetically."
        ]
      ]
    }
  },
  "models_used": [
    "deepseek",
    "claude-sonnet",
    "gemini-flash"
  ],
  "overall_confidence": 0.53889010989011
}